Literature DB >> 932691

Preparation and characterization of influenza virus cores.

M Reginster, M V Nermut.   

Abstract

Lipid-free influenza virus cores have been obtained by a three step procedure consisting of (a) treatment with proteolytic enzyme, (b) fixation with formaldehyde and (c) delipidization with saponin or deoxycholate. Several reagents proved efficient in removing the virus lipids as judged by morphological features and increased buoyant density, but only cores prepared by means of sodium deoxycholate have been characterized closely. Ultrathin sections revealed round bodies (about 65 nm in diam.) delineated by a single dense track and with an internal structure very similar to that of the complete virus particles. They contained both the nucleoprotein and the M-protein and no lipids. It is proposed to call the limiting structure which appears (3 to 4 nm thick in ultrathin sections) the core shell.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932691     DOI: 10.1099/0022-1317-31-2-211

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Monoclonal antibodies detect M-protein epitopes on the surface of influenza virions.

Authors:  L Joassin; C Vincenzotto; J M Cloes; M Bouchet; M Reginster
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Anti M-protein antibody response to type A or B natural influenza detected by solid phase enzyme linked immunosorbent assay and by complement fixation.

Authors:  L Joassin; M Reginster; D Vaira
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

3.  In Vitro Disassembly of Influenza A Virus Capsids by Gradient Centrifugation.

Authors:  Sarah Stauffer; Firat Nebioglu; Ari Helenius
Journal:  J Vis Exp       Date:  2016-03-27       Impact factor: 1.355

Review 4.  Structural Models for Roseolovirus U20 And U21: Non-Classical MHC-I Like Proteins From HHV-6A, HHV-6B, and HHV-7.

Authors:  Grant C Weaver; Richa Arya; Christine L Schneider; Amy W Hudson; Lawrence J Stern
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.